These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 19308891)
1. Laboratory monitoring of anticoagulation: where do we stand? Tripodi A; van den Besselaar A Semin Thromb Hemost; 2009 Feb; 35(1):34-41. PubMed ID: 19308891 [TBL] [Abstract][Full Text] [Related]
2. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
3. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation. Tripodi A; Palareti G J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239 [TBL] [Abstract][Full Text] [Related]
4. Emerging anticoagulants for the treatment of venous thromboembolism. Weitz JI Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267 [TBL] [Abstract][Full Text] [Related]
5. New anticoagulants for treatment of venous thromboembolism. Gross PL; Weitz JI Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):380-6. PubMed ID: 18296593 [TBL] [Abstract][Full Text] [Related]
6. Update in the treatment of venous thromboembolism. Garcia DA; Spyropoulos AC Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085 [TBL] [Abstract][Full Text] [Related]
7. New antithrombotic drugs: potential for use in oncology. Levine MN J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103 [TBL] [Abstract][Full Text] [Related]
9. [New anticoagulants: better knowledge, better prescriptions]. Boehlen F; de Moerloose P Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817 [TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. Sattari M; Lowenthal DT Am J Ther; 2011 Jul; 18(4):332-8. PubMed ID: 20535013 [TBL] [Abstract][Full Text] [Related]
11. [New anticoagulants in the treatment of venous thromboembolism]. Bura-Rivière A Rev Prat; 2013 Sep; 63(7):980-4. PubMed ID: 24167902 [TBL] [Abstract][Full Text] [Related]
12. New anticoagulants for treatment of venous thromboembolism. Weitz JI Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877 [TBL] [Abstract][Full Text] [Related]
13. New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors. Morris TA Clin Chest Med; 2010 Dec; 31(4):707-18. PubMed ID: 21047577 [TBL] [Abstract][Full Text] [Related]
14. Initial treatment of venous thromboembolism. Becattini C; Agnelli G; Emmerich J; Bura A; Weitz JI Thromb Haemost; 2006 Sep; 96(3):242-50. PubMed ID: 16953263 [TBL] [Abstract][Full Text] [Related]
15. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay. Barrett YC; Wang Z; Frost C; Shenker A Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714 [TBL] [Abstract][Full Text] [Related]
16. Heparin: from animal organ extract to designer drug. Middeldorp S Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Vergouwen MD; Roos YB; Kamphuisen PW Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676 [TBL] [Abstract][Full Text] [Related]
19. Advances in the management of venous thromboembolism. Schulman S Best Pract Res Clin Haematol; 2012 Sep; 25(3):361-77. PubMed ID: 22959552 [TBL] [Abstract][Full Text] [Related]
20. Development in anticoagulant therapy. van Doormaal FF; Büller HR; Middeldorp S Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]